Corporate press release

GEA’s factory in Elsdorf sets new standards in pharmaceutical production

March 22, 2024

GEA Pharmaceutical technology center - Side view (Copyright: © AIP Planungs GmbH)
  • Groundbreaking ceremony for GEA’s second “Factory of the Future” covering an area of over 40,000 m² in Elsdorf, Germany
  • Construction work meets the highest sustainability standards in line with the company’s manufacturing strategy
  • All 250 employees from the current location in Hürth to relocate to the new plant
  • GEA is investing EUR 80 million to further its growth in the pharmaceutical freeze-drying market
  • New factory scheduled to open in the second half of 2025
(from left to right): Otto Hoffmann (Representative Church Council), Johannes Giloth (Chief Operating Officer, GEA Group), Andreas Heller (Mayor, City of Elsdorf), Stefan Klebert (Chief Executive Officer, GEA Group), Johann Braun (Board Member, Group Max Bögl), Heinrich Meintrup (SVP BU Pharma & Healthcare, GEA), Marius Magnus Riepe (Managing Director, AIP Planungs GmbH), Michael Martin (Managing Director, AIP Planungs GmbH)

(from left to right): Otto Hoffmann (Representative Church Council), Johannes Giloth (Chief Operating Officer, GEA Group), Andreas Heller (Mayor, City of Elsdorf), Stefan Klebert (Chief Executive Officer, GEA Group), Johann Braun (Board Member, Group Max Bögl), Heinrich Meintrup (SVP BU Pharma & Healthcare, GEA), Marius Magnus Riepe (Managing Director, AIP Planungs GmbH), Michael Martin (Managing Director, AIP Planungs GmbH)

Construction of GEA’s new pharmaceutical technology center in Elsdorf, Germany, begins today – setting new industry benchmarks. The machinery and plant manufacturer is investing EUR 80 million in the new freeze-drying systems facility. These systems are used in the production of numerous injectable pharmaceuticals, including vaccines. The new facility is scheduled to open in the second half of 2025.

With people increasingly aware of the major role immunization plays in preventing disease, the market for vaccines is growing rapidly worldwide. In order to meet this rising demand, GEA opted to build a new plant, as capacities at the existing facility in Hürth were nearing their limits. All 250 employees are to relocate to the new plant.

“This investment will open the door to our onward growth as well as improved innovation opportunities in the pharmaceutical sector, which is strategically significant for us. The new plant will enable us to align even more closely with our customers’ needs and expand our leading market position,” says GEA CEO Stefan Klebert.

Construction starts on GEA’s second “Factory of the Future” covering over 40,000 m² 

Following the opening of the first factory in Poland in 2022, the second plant of its kind – covering an area of over 40,000 m² – is now being built in Germany.

At Elsdorf, state-of-the-art processes and working methods as well as the associated digitalization are the main focus alongside sustainable construction. Mobile devices coupled with the use of apps for production control and monitoring will help create an ergonomic and attractive workplace for employees. End-to-end document management and digital workflows will ensure efficient and targeted access to company-relevant information. Reliable material tracking will be made possible by the intelligent warehouse management system.

“With modular manufacturing structures and digital technologies that make our production more flexible and faster, we are setting new standards in the GEA network,” says GEA COO Johannes Giloth.

GEA Pharmaceutical technology center, Elsdorf - Aerial

GEA Pharmaceutical technology center, Elsdorf - Aerial

New facility meets the highest sustainability standards

“We develop sustainable solutions for the food and pharmaceutical industries to help protect future generations. So we need to reflect this also in our own actions. Ultimately, only an industrial base with a firm focus on sustainability will remain competitive and strong on exports going forward,” adds CEO Stefan Klebert.

This is why the new pharmaceutical technology center is going to be built according to the highest sustainability standards. Power will be generated by the company’s own photovoltaic system. The electricity will be stored in batteries to keep it available for charging electric vehicles, for example. No natural gas will be used. Heat recovered in system test runs can be used to heat and cool the plant.

A green roof will provide protection against hot weather for the building and employees as well as create pleasant air quality. A water retention system and minimum soil sealing will ensure that annual rainfall is used and distributed to optimum effect. Biodiversity at the site will be promoted by the green roof and an ecological compensation area on the property.

GEA Pharmaceutical technology center - South view (Copyright: © AIP Planungs GmbH)

GEA Pharmaceutical technology center - South view (Copyright: © AIP Planungs GmbH)

A strong signal for Elsdorf as a business location

For the town of Elsdorf, about half an hour’s drive from Hürth in the Rhein-Erft district, the new plant is an important signal of its importance as a business location.

"We warmly welcome GEA to our town and are delighted that the company has chosen Elsdorf. This shows once again how attractive Elsdorf and our region are as a business location. With the construction of the new GEA plant, we are getting a further important boost for structural change, as future-proof and valuable jobs will be located in our town. Our hard work is now bearing further fruit,” says Mayor Andreas Heller.

Lilian Schmalenstroer

CONTACT

Phone: +49 211 91362090

Media Relations

GEA Group Aktiengesellschaft

Peter-Müller-Str. 12


40468

Düsseldorf


Germany

+49 211 9136-0

GEA の概要

GEA は、世界レベルの食品製造プロセス技術を有するとともに、乳業、飲料、パーソナル・ホームケア、化学など食品以外の幅広い分野にも実績があり、2019年度の連結売上高は約49億ユーロとなりました。

最先端のプロセスソリューションと洗練されたプロセス機器を世界中のお客様に提供している国際企業です。 GEA は、お客様が抱える課題やニーズに対して、経験・実績に基づいた最適なソリューションを提供致します。。当グループでは、長期的に成長している食品と飲料分野が売上の約70%を占めています。2018年12月31日の時点で、GEAの総従業員数は約18,500人です。GEA は自社のビジネスエリアにおいて市場とテクノロジーのリーダーとなっています。当社は、ドイツ株価指数の MDAX主要銘柄に採用されています。
GEAの最新情報をお届け

GEAからのニュース配信にサインアップして頂ければ、GEAのイノベーションやストーリーの最新情報を受け取ることができます。

連絡先

ご要望をお伺いいたします。ご要望の詳細をご入力いただければ、お問い合わせに回答いたします。